RBC Capital analyst Ashish Sabadra maintained a Buy rating on MSCI (MSCI – Research Report) yesterday and set a price target of $675.00. The ...

The firm acknowledges that Sunoco faces downside risks, which could stem from a negative shift in commodity market conditions or the economics of potential future projects and mergers and acquisitions ...

RBC Capital Markets advised on a total of 34 deals ... Evercore was third with 19, Barclays came fourth with 18 and Goldman Sachs secured fifth spot with 16 deals. GlobalData’s league tables ...

$180,000 of RBC CAPITAL MARKETS LLC (FORMERLY REGISTERED AS ROYAL BANK OF CANADA) lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on ...

Barclays analyst Balaji Prasad maintained a Hold rating on Pacira Pharmaceuticals (PCRX – Research Report) today and set a price target of ...

RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager ...

But investors can still look forward to "solid" if more "moderate" returns in the year ahead, says RBC Capital Markets – and perhaps even better with the right stock investments. "The overall ...

Victory Capital (NASDAQ:VCTR – Free Report) had its target price upped by Barclays from $69.00 to $70.00 in a report released on Friday morning,Benzinga reports. Barclays currently has an equal weight ...

"Prices have moved up nearly 16% since Thursday with no 'normal' reasons that could justify this price action," Tyler Broda, an RBC Capital Markets analyst, said in a February 1 research note.

RBC said there will likely be a delay in the ... outperform') has been slashed to 435p from 540p while the target for Barclays ('outperform') has been maintained at 285p.